Malaria Vaccine Developer Sanaria Inc.. and the Institute for Bioscience and Biotechnology Research of the University of Maryland College Park Awarded Collaborative, US $3M National Institutes of Health (NIH) Phase II Small Business Innovation Research Grant
6/14/2012 10:21:35 AM
More...
|
Malaria Parasite and Mosquito Products and Assay Services Available for Sale by Sanaria Inc.
6/30/2011 5:58:55 AM
More...
|
Sanaria Inc. Receives Multi-Year U.S. NIH Phase II Small Business Innovation Research Grant to Develop a Genetically Attenuated Whole Parasite Malaria Vaccine
2/23/2010 11:32:06 AM
More...
|
Sanaria Inc. Release: Phase 1 Trial of Whole-Parasite Malaria Vaccine to Begin
4/23/2009 8:27:34 AM
More...
|
Malaria Vaccine Plant Sanaria Inc. Takes a Gamble
10/29/2007 10:06:23 AM
More...
|
Biotech Company Sanaria Inc. To Open New Malaria Vaccine Plant
10/25/2007 12:30:48 AM
More...
|
Sanaria Inc. Receives Multi-Year $3.47 Million U.S. FDA Phase I And Phase II Small Business Innovation Research Grants To Enhance Development Of Its Malaria Vaccine
1/29/2007 12:37:40 PM
More...
|